Below are the financial statements of CR Pharma, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in billions of CNY | 2024 | 2023 |
|---|---|---|
| Revenue | 257.67a | 244.7a |
| Cost of sales | -216.98a | -206.37a |
| Gross profit | 40.69a | 38.34a |
| Other income | 1.8a | 1.77a |
| Other gains and losses | -1.64a | -1.56a |
| Selling and distribution expenses | -19.81a | -18.91a |
| Administrative expenses | -6.73a | -6.33a |
| Other expenses, net | -2.15a | -2.04a |
| Finance income | 0.68a | 0.59a |
| Finance costs | -2.28a | -2.39a |
| Finance costs, net | -1.6a | -1.8a |
| Share of profits of associates and joint ventures | 0.37a | 0.42a |
| Profit before taxation | 10.93a | 9.88a |
| Income tax expense | -2.53a | -2.11a |
| Profit for the year | 8.4a | 7.78a |
| Attributable to | — | — |
| Equity shareholders of the company | 3.35a | 3.85a |
| Non-controlling interests | 5.05a | 3.92a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore CR Pharma’s data sources below and access millions more through our Disclosure Search.